BN Business News
Add your company to Business Communicator →

Business · 19/11/20261 min read

Genprex Presents Preclinical Data Identifying TROP2 as a Potential Predictive Biomarker for Reqorsa® Gene Therapy in Lung Cancer

EDITORIAL ILLUSTRATIONBBusinessBN
Illustration generated by Business News; it is not a source photograph.

Summary

Data Presented at the 2026 EORTC-NCI-AACR Symposium Show TROP2 Levels May Help Predict Which Tumors Respond to Reqorsa® and Modulating TROP2 May Enhance Efficacy AUSTIN, Texas, Nov. 19, 2026 — Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage...

Original source language: PR Newswire — Global News ReleasesOpen original release →

Explore insights

Business insights →